LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PD0325901 | 10.0 | uM | LJP5 | 1 | C01 | 72 | hr | 1401 | 1395 | 4223 | 0.3303 | -0.0023 |
| SK-BR-3 | PD0325901 | 10.0 | uM | LJP5 | 2 | C01 | 72 | hr | 1401 | 2811 | 4223 | 0.6656 | 0.4995 |
| SK-BR-3 | PD0325901 | 10.0 | uM | LJP5 | 3 | C01 | 72 | hr | 1401 | 3141 | 4223 | 0.7438 | 0.6165 |
| SK-BR-3 | PD0325901 | 10.0 | uM | LJP6 | 1 | E01 | 72 | hr | 1401 | 1748 | 4223 | 0.4139 | 0.1228 |
| SK-BR-3 | PD0325901 | 10.0 | uM | LJP6 | 2 | E01 | 72 | hr | 1401 | 2533 | 4223 | 0.5998 | 0.4010 |
| SK-BR-3 | PD0325901 | 10.0 | uM | LJP6 | 3 | E01 | 72 | hr | 1401 | 2249 | 4223 | 0.5326 | 0.3004 |
| SK-BR-3 | PD173074 | 10.0 | uM | LJP6 | 1 | I07 | 72 | hr | 1401 | 2336 | 4223 | 0.5532 | 0.3312 |
| SK-BR-3 | PD173074 | 10.0 | uM | LJP6 | 2 | I07 | 72 | hr | 1401 | 2290 | 4223 | 0.5423 | 0.3149 |
| SK-BR-3 | PD173074 | 10.0 | uM | LJP6 | 3 | I07 | 72 | hr | 1401 | 2347 | 4223 | 0.5558 | 0.3351 |
| SK-BR-3 | PD184352 | 10.0 | uM | LJP5 | 1 | L07 | 72 | hr | 1401 | 3132 | 4223 | 0.7416 | 0.6133 |
| SK-BR-3 | PD184352 | 10.0 | uM | LJP5 | 2 | L07 | 72 | hr | 1401 | 3193 | 4223 | 0.7561 | 0.6349 |
| SK-BR-3 | PD184352 | 10.0 | uM | LJP5 | 3 | L07 | 72 | hr | 1401 | 3307 | 4223 | 0.7831 | 0.6753 |
| SK-BR-3 | Pelitinib | 10.0 | uM | LJP5 | 1 | I13 | 72 | hr | 1401 | 1265 | 4223 | 0.2995 | -0.0484 |
| SK-BR-3 | Pelitinib | 10.0 | uM | LJP5 | 2 | I13 | 72 | hr | 1401 | 974 | 4223 | 0.2306 | -0.1515 |
| SK-BR-3 | Pelitinib | 10.0 | uM | LJP5 | 3 | I13 | 72 | hr | 1401 | 1024 | 4223 | 0.2425 | -0.1338 |
| SK-BR-3 | PF431396 | 10.0 | uM | LJP5 | 1 | E07 | 72 | hr | 1401 | 1532 | 4223 | 0.3628 | 0.0462 |
| SK-BR-3 | PF431396 | 10.0 | uM | LJP5 | 2 | E07 | 72 | hr | 1401 | 1217 | 4223 | 0.2882 | -0.0654 |
| SK-BR-3 | PF431396 | 10.0 | uM | LJP5 | 3 | E07 | 72 | hr | 1401 | 1286 | 4223 | 0.3045 | -0.0409 |
| SK-BR-3 | PF477736 | 10.0 | uM | LJP5 | 1 | J19 | 72 | hr | 1401 | 1042 | 4223 | 0.2467 | -0.1274 |
| SK-BR-3 | PF477736 | 10.0 | uM | LJP5 | 2 | J19 | 72 | hr | 1401 | 1298 | 4223 | 0.3074 | -0.0367 |
| SK-BR-3 | PF477736 | 10.0 | uM | LJP5 | 3 | J19 | 72 | hr | 1401 | 1231 | 4223 | 0.2915 | -0.0604 |
| SK-BR-3 | PF562271 | 10.0 | uM | LJP6 | 1 | F13 | 72 | hr | 1401 | 1176 | 4223 | 0.2785 | -0.0799 |
| SK-BR-3 | PF562271 | 10.0 | uM | LJP6 | 2 | F13 | 72 | hr | 1401 | 1116 | 4223 | 0.2643 | -0.1012 |
| SK-BR-3 | PF562271 | 10.0 | uM | LJP6 | 3 | F13 | 72 | hr | 1401 | 1305 | 4223 | 0.3090 | -0.0342 |
| SK-BR-3 | PHA-665752 | 10.0 | uM | LJP5 | 1 | F13 | 72 | hr | 1401 | 670 | 4223 | 0.1587 | -0.2593 |